Top Markets
Coin of the day
Proteonomix, Inc. Proteonomix, Inc.

Proteonomix, Inc.

PROT
株式のランク #42572
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics... Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$791.00
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Proteonomix, Inc. (PROT)

カテゴリー

Proteonomix, Inc.(PROT)のP/S比率
2026 時点のP/S比率 TTM: 0
Proteonomix, Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Proteonomix, Inc. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率